Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

» OMBP's 10-Y Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with OMBP

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )



Valuation & Return


Business Description

Industry: Biotechnology » Biotechnology
Compare: » details
Omni Bio Pharmaceutical Inc was incorporated under the name of Across America Financial Services, Inc. On March 31, 2009 Across America Financial Services, Inc. (Across America) completed the acquisition of Apro Bio Pharmaceutical Corporation (Apro Bio) pursuant to the terms of the Agreement of Merger and Plan of Reorganization, as amended (the Merger) among Across America, Apro Bio and Across America Acquisition Corp. (AAAC), a Colorado corporation and a wholly-owned subsidiary of Across America. Under the terms of the Merger, AAAC was merged into Apro Bio, and Apro Bio became a wholly-owned subsidiary of the Company. On May 27, 2009 Across America changed its name to Omni Bio Pharmaceutical, Inc. (Omni). It intends to commercialize a broad patent portfolio licensed from the UCHSC, and a component of these applications involves use of existing FDA approved drugs to treat a variety of bacterial and viral diseases, biohazards and transplant rejection. It is the licensee of filed, but not yet issued, patents related to composition of matter and method of use for an existing FDA approved drug, Alpha 1 Antitrypsin (AAT), for treating organ transplantation, including islet transplantation for the treatment of diabetes and bacterial infections including bacterial pneumonia, tuberculosis and anthrax. It has also licensed an existing patent for the treatment of viral infection including HIV, influenza and potentially the 'bird flu' virus. The Company plans to acquire and develop existing and novel therapies that have the potential to move through clinical trials quickly, shepherd them through the FDA approval processes and advance them through commercialization. This approach is similar to what developed for the drug Minoxodil (trade named Rogaine(r)), which previously had come off its initial patents to treat high blood pressure. It faces intense competition from a range of pharmaceutical, biotechnology and diagnostic companies, as well as academic and research institutions and government agencies. Regulations in the U.S. and other countries would have a significant impact on its research, product development and manufacturing activities and would be a significant factor in the marketing of its products.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)